|
Volumn 14, Issue 3, 2016, Pages 212-213
|
Leucoreduction of blood components: Clinical and molecular evidence
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD COMPONENT;
BLOOD TRANSFUSION;
CLINICAL EFFECTIVENESS;
CLINICAL TRIAL (TOPIC);
CYTOMEGALOVIRUS;
EDITORIAL;
EVIDENCE BASED PRACTICE;
GAMMA IRRADIATION;
GRAFT VERSUS HOST REACTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LABORATORY TEST;
LEUCOREDUCTION;
LEUKAPHERESIS;
METABOLOMICS;
NONHUMAN;
PRACTICE GUIDELINE;
PROTEOMICS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TRANSFUSION RELATED ACUTE LUNG INJURY;
TREATMENT INDICATION;
VIRUS TRANSMISSION;
BLOOD COMPONENT THERAPY;
BLOOD COMPONENT TRANSFUSION;
HUMANS;
LEUKOCYTE REDUCTION PROCEDURES;
|
EID: 84977156855
PISSN: 17232007
EISSN: None
Source Type: Journal
DOI: 10.2450/2015.0291-15 Document Type: Editorial |
Times cited : (6)
|
References (6)
|